High dose-rate intracavitary brachytherapy for carcinoma in situ of the vagina occurring after hysterectomy: A rational prescription of radiation dose

American Journal of Obstetrics and Gynecology

Volumn 187, Issue 2, 2002, Pages 360-364

  Teruya, Yoko ^a   Sakumoto, Kaoru ^a   Moromizato, Hidehiko ^a   Toita, Takafumi ^a   Ogawa, Kazuhiko ^a   Murayama, Sadayuki ^a   Kanazawa, Koji ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

High dose rate intracavitary brachytherapy; Vaginal

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CARCINOMA IN SITU; CLINICAL ARTICLE; FEMALE; HEMATURIA; HUMAN; HYSTERECTOMY; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; RECTUM HEMORRHAGE; VAGINA CARCINOMA; VAGINA MUCOSA;

EID: 0036679159     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.123202     Document Type: Article

References (15)

1. Loop electrosurgical excision procedure for partial upper vaginectomy
2. Upper vaginectomy for in situ and occult, superficial invasive carcinoma of the vagina
3. 2
4. Cavitational ultrasonic surgical aspiration for the treatment of vaginal intraepithelial neoplasia
5. Topical 5-fluorouracil treatment of vaginal intraepithlial neoplasia
6. Definitive irradiation in carcinoma of the vagina: Long-term evaluation of results
7. Definitive radiotherapy for carcinoma of the vagina: Outcome and prognostic factors
8. Radiotherapy in the management of vaginal intraepithelial neoplasia after hysterectomy
9. High-dose-rate brachytherapy in the management of high-grade intraepithelial neoplasia of the vagina
10. High-dose-rate intracavitary brachytherapy in the management of cervical and vaginal intraepithelial neoplasia
11. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization of Research and Treatment of Cancer (EORTC)
12. Vaginal intraepithelial neoplasia: Risk factors for persistence, recurrence, and invasion and its management
13. Natural history of vaginal intraepithelial neoplasia
14. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation
15. Prediction of severe late complications in fractionated, high-dose-rate brachytherapy in gynecological applications